Led · Series A · Oct 2022

SweGaN develops and manufactures GaN-on-SiC epitaxial wafers for wide-bandgap semiconductor applications. The company serves markets including RF and power electronics for 5G, satellite communications, telecom infrastructure, defence radar systems and high-efficiency power conversion in data centres. SweGaN plans to use the new funding to expand production capacity, accelerate R&D of next-generation GaN-on-SiC materials, and strengthen its commercial presence globally. Management stated the financing represents an up-round and will support hiring and infrastructure investment as the company scales. The round increases SweGaN’s total funding to $41M, reflecting recent commercial progress and investor confidence.

Participated · Seed · Sep 2021

Thiozen commercializes a proprietary process that converts sour gas waste streams into low-cost, low-emission hydrogen. The company is an MIT spinout led by Ryan Gillis and has validated its technology in an in-field pilot unit in the Permian Basin. Thiozen intends to install its proprietary technology at a gas-processing site in Alberta to produce zero-emission hydrogen. The hydrogen produced will be used to decarbonize onsite operations and to demonstrate economically viable decarbonization for remote industrial locations. Thiozen received $3.2M in project funding for its Alberta project, administered by Emissions Reduction Alberta and Alberta Innovates, as part of a broader provincial commitment to advance the hydrogen economy. Thiozen develops a patented chemical cycle that converts hydrogen sulfide from sour gas waste streams into low-cost, low-emission hydrogen. The company recently validated its technology in an in-field pilot unit in the Permian Basin and plans to use new funding to advance commercial readiness and scale commercialization. Thiozen says its process can reduce global greenhouse gas emissions by more than 300 million metric tons per year and improve air quality near hydrogen infrastructure. The company will apply the NSF grants to perform additional experimental campaigns and projects demonstrating performance versus legacy hydrogen-production methods. Thiozen is a three-year-old MIT spinout headquartered in Pasadena, California. Thiozen is commercializing a novel process to produce low-cost, low-emission hydrogen from hydrogen sulfide and water. The technology was invented at MIT by Dr. Ryan Gillis and Professor William Green, and the company was founded out of MIT in 2020. Thiozen's leadership includes CEO Dr. Ryan Gillis, COO Ajay Bawa, and board member Professor William Green. The company is based in Beverly, MA at Northshore InnoVentures and is described as Boston, MA-based in reports. Thiozen raised $3m in seed funding and intends to use the funds to scale its technology to a commercial demonstration. Investors in the round included Eni Next, Good Growth Capital and Mount Wilson Ventures.

Led · Seed · May 2018

SeqOnce Biosciences is a Pasadena, CA-based life science company developing products for next-generation sequencing for the research and clinical markets. Its core product is a Library Construction kit featuring a single-tube, three-step, highly efficient protocol that includes fragmentation. The kit can be applied to DNA from any sample source and can be adapted to most sequencing applications. The company is led by co-founder and CSO Joseph Dunham, Ph.D., and CEO Chris Angermayer. SeqOnce completed a $1M seed financing to support commercialization of its library construction kit. The funds will be deployed to advance commercial availability and market adoption.